Recent Finacing
Recent Raise
NeoChord develops minimally invasive beating‑heart mitral valve repair systems, notably the DS1000 transapical artificial chordae delivery platform (CE‑marked), plus imaging and edge‑to‑edge transcatheter repair technologies.
